BAJAJHCARE331.50

Bajaj Healthcare Limited

· Pharma & Health
₹ CrorePeersTHEMISMEDLINCOLNWANBURYSIGACHIAHCLANUHPHRAMRUTANJANMcap ₹1,116 Cr
View
In ₹ Crore except Per Share
12 Months Ending
FY24
31/03/2024
FY25
31/03/2025
FY26
31/03/2026
Last 12M
30/06/2026
Non-current Assets
+ Property, Plant & Equipment252.0236.6247.2247.2
+ Capital Work-in-Progress4.83.47.97.9
+ Other Intangibles0.71.91.01.0
+ Intangibles under Development1.80.00.00.0
+ Non-current Investments0.00.00.00.0
+ Other Non-current Financial Assets2.75.613.713.7
Non-current Financial Assets2.75.613.713.7
+ Deferred Tax Assets21.918.910.710.7
+ Other Non-current Assets0.05.73.73.7
Total Non-current Assets283.9272.1284.2284.2
Current Assets
+ Inventories144.0161.9216.0216.0
+ Trade Receivables180.2251.7233.9233.9
+ Cash & Cash Equivalents2.22.637.237.2
+ Other Bank Balances0.81.80.80.8
+ Other Current Financial Assets35.033.45.25.2
Current Financial Assets218.2289.6277.1277.1
+ Other Current Assets42.334.076.076.0
Total Current Assets405.7485.4569.1569.1
Total Assets765.1833.0923.2923.2
Equity
+ Equity Share Capital13.815.816.816.8
+ Other Equity / Reserves264.6450.4516.2516.2
Equity — Owners of Parent278.4466.2533.0533.0
Total Equity278.4466.2533.0533.0
Liabilities
+ Borrowings — Non-current65.064.747.647.6
+ Other Non-current Financial Liab0.60.33.03.0
Non-current Financial Liabilities65.664.950.650.6
+ Provisions — Non-current6.15.07.27.2
Non-current Liabilities71.769.957.757.7
+ Borrowings — Current267.0158.0185.9185.9
+ Trade Payables89.495.5115.3115.3
+ Other Current Financial Liab16.610.516.116.1
Current Financial Liabilities373.1263.9317.3317.3
+ Provisions — Current0.11.31.01.0
+ Other Current Liabilities2.57.11.21.2
Current Liabilities375.7272.3319.6319.6
Total Liabilities486.8366.9390.2390.2
Total Equity & Liabilities765.1833.0923.2923.2
Assets — additional as-filed lines
+ Non-current Assets Held for Sale75.575.569.969.9
+ Current Tax Assets1.10.00.0
Liabilities — additional as-filed lines
+ Liabilities of Disposal Group Held for Sale39.424.712.912.9
Trade Payables — MSME split
+ Dues to Micro & Small — Current8.46.56.5
+ Dues to Other Creditors — Current87.0108.7108.7
Regulatory Disclosures — filed alongside, not part of the B/S
+ Funds Utilised150.0
+ Original Allocation150.0
+ Modified Allocation150.0
As filed, sign as filed — read the label, not the sign. A line appears only when the company tagged that concept in at least one period shown, so depth follows the filer: pre-Ind-AS, insurance and NBFC blocks stay hidden unless they were actually reported. Alternate tags for the same idea (e.g. two spellings of a deferred-tax element) are kept as separate lines rather than merged, because merging them would be a guess. Ratios, per-share figures and counts render as raw numbers, not ₹ Crore. No consensus estimates → no Est columns. Click any row to chart it.
« ‹ › »Latest: FY26 · ConsolidatedFA Financial Analysis · alphave
Data & compliance. Descriptive financial information from official NSE/BSE filings — for information and education only, not investment advice, a recommendation, or a valuation. Standalone = parent entity; consolidated includes subsidiaries. Historical multiples pair each fiscal year's filed figures with that FY-end market close; the Current column uses the last close with the latest filed annuals. Figures are cross-verified via accounting identities and NSE×BSE agreementXBRL cross-verified ✓ 95%.